Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06257316 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Appropriate Dosage of Vasopressor in Neonates and Infants

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria shortened, about 21 words Secondary endpoints: 6 to 7 · Study description expanded, about 1 wordv2 Show 2 more changesShow less
    • Secondary endpoints: 6 to 7
    • Study description expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this study, the investigators will evaluate cerebral blood flow before and after drug infusion using ultrasound to suggest blood pressure criteria and dosage of ephedrine, a vasopressor, to maintain adequate cerebral blood flow in neonates and infants undergoing surgery and anesthesia.
Trial Details
NCT Number NCT06257316
Lead Sponsor Seoul National University Hospital
Conditions Hypotension, Neonatal Hypotension, Intraoperative Complications
Enrollment 132 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov